Adam J. Widman

1.2k citations
12 papers · 116 indexed · h-index 7
Topics
Cancer Genomics and Diagnostics (3 papers)Immune Cell Function and Interaction (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)

In The Last Decade

Adam J. Widman

10 papers receiving 114 citations

Peers

Adam J. Widman
Comparison fields: 5 of 41
  • Oncology 43
  • Immunology 36
  • Cell Biology 25
  • Molecular Biology 21
  • Genetics 20
Replace Leilei Wen with:
Leilei Wen China
Hamida Mohamdi France
F. Lejeune Belgium
Suzannah August United Kingdom
Natasha Silke Australia
Patricia J. Ahl Singapore
Sam Lee Canada
Zhengwei Zhu China
Hanan Khoury-Haddad Israel
F. Cuéllar Spain
Adam J. Widman relative to Leilei Wen China Leilei Wen's profile →
Citations per field
00.5×1.7×
Leilei Wen · 1×
Citations per year

Countries citing papers authored by Adam J. Widman

Since Specialization
Citations

This map shows the geographic impact of Adam J. Widman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Widman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Widman more than expected).

Fields of papers citing papers by Adam J. Widman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Widman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Widman. The network helps show where Adam J. Widman may publish in the future.

Co-authorship network of co-authors of Adam J. Widman

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Widman. A scholar is included among the top collaborators of Adam J. Widman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Widman. Adam J. Widman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 15
5 31
6 10
7 10
8 21
9 1
10 11
11
Steroid hormone receptors in male breast diseases.
15
12
[Estrogen and progesterone receptors in uterine cervix].
1

About Adam J. Widman

Adam J. Widman is a scholar working on Cancer Research, Oncology and Immunology, having authored 12 papers that have together received 116 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Immune Cell Function and Interaction (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Dermatology (16 citations), Immunology (36 citations) and Oncology (43 citations). Adam J. Widman has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Ran Reshef, Behnaz Taidi, M. M. Brentani, Jedd D. Wolchok, Debra K. Czerwinski, John M. Timmerman, Edward C. Kuan, Bevin Cohen, Mini Kamboj and Míriam Teresa Paz Lopes. Their work appears in journals such as Blood, Clinical Cancer Research and Science Signaling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026